Literature DB >> 7072544

Pyruvate kinase in human brain tumours. Its significance in the treatment of gliomas.

C W van Veelen, H Verbiest, K J Zülch, B van Ketel, M J van der Vlist, A M Vlug, G Rijksen, G E Staal.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1982        PMID： 7072544     DOI： 10.1007/bf01740079

Source DB:  PubMed          Journal:  Acta Neurochir (Wien)        ISSN： 0001-6268            Impact factor:   2.216


× No keyword cloud information.
  11 in total

1.  L-alpha-alanine inhibition of pyruvate kinase from tumors of the human central nervous system.

Authors:  C W van Veelen; H Verbiest; K J Zülch; B A van Ketel; M J van der Vlist; A M Vlug; G Rijksen; G E Staal
Journal:  Cancer Res       Date:  1979-10       Impact factor: 12.701

2.  Pyruvate kinase isozymes in neurons, glia, neuroblastoma, and glioblastoma.

Authors:  S W Tolle; R D Dyson; R W Newburgh; J M Cardenas
Journal:  J Neurochem       Date:  1976-12       Impact factor: 5.372

3.  Summation: molecular mechanisms of gene regulation--session 3.

Authors:  S Weinhouse
Journal:  Cancer Res       Date:  1976-11       Impact factor: 12.701

4.  Isozymes of pyruvate kinase from human brain, meningiomas, and malignant gliomas.

Authors:  C W van Veelen; H Verbiest; A M Vlug; G Rijksen; G E Staal
Journal:  Cancer Res       Date:  1978-12       Impact factor: 12.701

Review 5.  Developmental gene expression in cancer.

Authors:  K H Ibsen; W H Fishman
Journal:  Biochim Biophys Acta       Date:  1979-08-10

Review 6.  Metabolism and isoenzyme alterations in experimental hepatomas.

Authors:  S Weinhouse
Journal:  Fed Proc       Date:  1973-12

Review 7.  Isozymes and cancer.

Authors:  F Schapira
Journal:  Adv Cancer Res       Date:  1973       Impact factor: 6.242

Review 8.  Enzymology of cancer cells (first of two parts).

Authors:  G Weber
Journal:  N Engl J Med       Date:  1977-03-03       Impact factor: 91.245

9.  Isoenzymes of hexokinase in the developing, normal and neoplastic human brain.

Authors:  M J Bennett; W R Timperley; C B Taylor; A S Hill
Journal:  Eur J Cancer       Date:  1978-02       Impact factor: 9.162

10.  New dimensions in the biology of cancer.

Authors:  S Weinhouse
Journal:  Cancer       Date:  1980-06-15       Impact factor: 6.860
View more
  5 in total

1.  Pyruvate kinase inhibition in the diagnosis of gliomas with an intermediate degree of malignancy.

Authors:  H W Mostert; N J de Both; E H Rhijnsburger; W M Mackay; J H van den Berge; S Z Stefanko
Journal:  Acta Neuropathol       Date:  1986       Impact factor: 17.088

2.  Glucose metabolism in human gliomas: correspondence of in situ and in vitro metabolic rates and altered energy metabolism.

Authors:  J Galarraga; D J Loreck; J F Graham; R L DeLaPaz; B H Smith; D Hallgren; C J Cummins
Journal:  Metab Brain Dis       Date:  1986-12       Impact factor: 3.584

3.  Regulation of the pentose phosphate pathway in human astrocytes and gliomas.

Authors:  D J Loreck; J Galarraga; J Van der Feen; J M Phang; B H Smith; C J Cummins
Journal:  Metab Brain Dis       Date:  1987-03       Impact factor: 3.584

4.  Discrimination between neuronal and glial cell tumours by pyruvate kinase electrophoresis.

Authors:  C W van Veelen; G Rijksen; G E Staal
Journal:  Acta Neurochir (Wien)       Date:  1988       Impact factor: 2.216

5.  Enzymes of glucose metabolism in cultured human gliomas: neoplasia is accompanied by altered hexokinase, phosphofructokinase, and glucose-6-phosphate dehydrogenase levels.

Authors:  J E Dominguez; J F Graham; C J Cummins; D J Loreck; J Galarraga; J Van der Feen; R DeLaPaz; B H Smith
Journal:  Metab Brain Dis       Date:  1987-03       Impact factor: 3.584
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.